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Exposure of cardiac myocytes to hyposmotic solution stimulates slowly-activating delayed-rectifying K+ current (IKs) via unknownmechanisms. In
the present study, IKs was measured in guinea-pig ventricular myocytes that were pretreated with modulators of cell signaling processes, and then
exposed to hyposmotic solution. Pretreatmentwith compounds that (i) inhibit serine/threonine kinase activity (10–100μMH89; 200μMH8; 50μMH7;
1μMbisindolylmaleimide I; 10μMLY294002; 50μMPD98059), (ii) stimulate serine/threonine kinase activity (1–5μMforskolin; 0.1μMphorbol-12-
myristate-13-acetate; 10 μMacetylcholine; 0.1 μM angiotensin II; 20 μMATP), (iii) suppress G-protein activation (10 mMGDPβS), or (iv) disrupt the
cytoskeleton (10 μM cytochalasin D), had little effect on the stimulation of IKs by hyposmotic solution. In marked contrast, pretreatment with tyrosine
kinase inhibitor tyrphostin A25 (20 μM) strongly attenuated both the hyposmotic stimulation of IKs in myocytes and the hyposmotic stimulation of
current in BHK cells co-expressing Ks channel subunits KCNQ1 and KCNE1. Since attenuation of hyposmotic stimulation was not observed in
myocytes and cells pretreated with inactive tyrphostin A1, we conclude that TK has an important role in the response of cardiac Ks channels to
hyposmotic solution.
© 2006 Elsevier B.V. All rights reserved.Keywords: Guinea-pig ventricular myocytes; Ks channels hyposmotic solution; Kinase inhibitors; GDPβS; Cytochalasin D1. Introduction
Slowly-activating delayed-rectifier Ks channels play an
important role in the repolarization of the cardiac action potential
[1,2], and loss-of-function mutations in the pore (KCNQ1) and
auxiliary (KCNE1) subunits that form the channels cause serious
cardiac disorders, including long QT syndrome and atrial
fibrillation [3–5]. Among the factors known to have a strong
influence on the activity of these channels is the transmembrane
distribution of osmolytes. When guinea-pig ventricular myocytes
are exposed to hyposmotic solution, the amplitude of the whole-
cell current carried by Ks channels (IKs) can increase by as much
as two-fold [6,7].
There is little known about the intracellular signaling processes
that may be involved in the hyposmotic stimulation of cardiac IKs.
In a study on guinea-pig ventricular myocytes, Groh et al. [8]
found that pretreatment with protein kinase A (PKA) or protein
kinase C (PKC) inhibitor had little effect on the increase in IKs⁎ Corresponding author. Tel.: +1 902 494 3392; fax: +1 902 494 1300.
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doi:10.1016/j.bbamem.2006.05.023amplitude induced by hyposmotic solution. In regard to a possible
role for protein tyrosine kinase (TK), Zhou et al. [9] observed that
pretreatment with TK inhibitor genistein (50 μM) partially
inhibited the stimulation of canine ventricular IKs by hyposmotic
solution; on the other hand, Kubota et al. [10] found that similar
pretreatment had no significant effect on the hyposmotic
stimulation of current in COS-7 cells expressing KCNQ1 and
KCNQ1/KCNE1 channels.
We have re-investigated the possible involvement of PKA,
PKC, and TK in the hyposmotic stimulation of cardiac IKs, and
also investigated the roles of other signaling molecules known to
be activated by hyposmotic swelling, including phosphatidylino-
sital-3-kinase (PI3-K), mitogen-activated protein kinases
(MAPKs), and G-proteins [11–13].
2. Materials and methods
2.1. Preparation of myocytes
Adult guinea-pigs (250–300 g) were killed by cervical dislocation in accord
with Canadian and Dalhousie University regulations on animal experimentation.
Hearts were quickly removed, mounted on a Langendorff column, and perfused
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contained (in mM) NaCl 125, KCl 5, MgCl2 1.2, taurine 20, glucose 20, and N-2-
hydroxyethylpiperazine-N′-2-ethanesulfonic acid (HEPES) 5 (pH 7.4), as well as
0.08–0.12 mg/ml collagenase (Yakult Pharmaceutical Co., Tokyo, Japan). On
completion of collagenase digestion, the heart tissue was minced, and myocytes
were dispersed in a high-K+, nutrient-supplemented storage solution (22 °C) that
contained KCl 30, KOH 80, KH2PO4 30, MgSO4 3, glutamic acid 50, taurine 20,
glucose 20, ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid
(EGTA) 0.5, and HEPES 10 (pH 7.4 with KOH).
2.2. Electrophysiology
2.2.1. Myocytes
A few drops of myocyte suspension were placed in a 0.3-ml chamber mounted
on the stage of an inverted phase-contrast microscope, and the chamber was
perfused with bathing solution (see below) at a flow rate near 2 ml/min. Rod-
shaped quiescent myocytes were voltage-clamped using the standard ruptured-
patch method. Recording pipettes were fabricated from thick-walled borosilicate
glass capillaries (H15/10/137, Jencons Scientific Ltd., Leighton Buzzard, UK), andFig. 1. Effects of hyposmotic 0.75T solution and chromanol 293B on IKs. (A) Results
2-s depolarizations applied just before (isosmotic 1T) and ≈5 min after successive
chromanol 293B, and hyposmotic solution once again (Wash). Pulse frequency 0.1
relationships obtained from this experiment. (B) Time course of the changes in IKs tai
Time on this and similar plots is referenced to patch-breakthrough time. (C) Inhibit
solution. IKs amplitude was measured as in B. Number of myocytes in parentheses.had resistances of 2–3 MΩ when filled with pipette solution. Pipette offsets were
nulled prior to patch formation, and liquid junction potentials (≈−10 mV) were
offset during data analysis. Series resistance ranged between 3 and 5MΩ, and was
compensated by 60–80%. Membrane currents were recorded with an EPC-9
amplifier (HEKA Electronics, Mahone Bay, NS, Canada), filtered at 3 kHz, and
digitized with Pulse software (HEKA Electronics) at a sampling rate of 12 kHz.
Data files were converted from Pulse to Axon (Axon Instruments, Union City, CA,
USA) format, and analyzed with Clampfit electrophysiology software. Experi-
ments on myocytes were conducted at 36 °C.
2.2.2. Transfected BHK cells
Baby hamster kidney (BHK) cells were seeded onto 22 mm glass coverslips,
and cultured as previously described [14]. One day after seeding, cells were co-
transfectedwith humanKCNQ1-, humanKCNE1-, and green fluorescence protein
(GFP)-containing pIRES vectors; the efficiency of transfectionwas assessed by the
intensity of cell fluorescence at 470 nm excitation wavelength. Electrophysiolog-
ical experiments were conducted 24 to 72 h after transfection. Fragments of
coverslipswere placed in the perfusion bath, andwhole-cell currents were recorded
from individual cells expressing KCNQ1/KCNE1 channels. The transfected cellsfrom a representative myocyte. Top: records of currents elicited by sequences of
switches to hyposmotic solution, hyposmotic solution that contained 50 μM
Hz. The dashed line indicates zero-current level. Bottom: tail current–voltage
l amplitude in a myocyte depolarized from −30 to +50 mV for 500 ms at 0.1 Hz.
ory effect of chromanol 293B on IKs in myocytes superfused with 1T or 0.75T
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converted and analyzed as outlined above for myocytes. Experiments on trans-
fected cells were performed at room temperature.
2.3. Bathing and pipette solutions
Isosmotic (1T) K+-, Ca2+-free solution contained (in mM) NaCl 70, MgCl2 1,
glucose 10, D-mannitol 140, and HEPES 5 (pH 7.4; ≈297 mOsmol/kg); the
solution also contained 0.2 mM Cd2+ to suppress inward cationic currents.
Hyposmotic (0.75T) solution (pH 7.4; ≈215 mOsmol/kg) contained 70 mM
instead of 140 mM mannitol. The standard pipette-filling solution contained (in
mM) KCl 40, potassium aspartate 106, MgCl2 4.8, K2ATP 4, MgATP 1, EGTA 5,
and HEPES 5 (pH 7.2 with KOH).
2.4. Chemicals and drugs
All chemicals used in making solutions were purchased from Sigma-Aldrich
(Oakville, ON, Canada) and were of the highest purity grade available.
Acetylcholine (Calbiochem, La Jolla, CA, USA), human angiotensin II (Calbio-
chem), and NaATP (Sigma-Aldrich) were prepared as aqueous stock solutions, and
isoprenaline (Calbiochem) was prepared as an aqueous stock solution that contained
1 mM ascorbic acid to prevent drug oxidation. E4031 (Eisai, Tokyo, Japan),
thiopentone (Abbott, Saint-Laurent, PQ, Canada), chromanol 293B (Aventis,
Strasbourg, France), and cytochalasin D (Sigma-Aldrich) were directly dissolved in
bathing solutions, and guanosine 5′-O-(2-thiodiphosphate) trilithium (GDPβS) was
dissolved in pipette solutionwith lowered potassium aspartate. BisindolylmaleimideFig. 2. Lack of effect of H89 and H8 on the stimulation of IKs by hyposmotic solution. (A
then exposed to hyposmoticH89 solution for 6min. Left: IKs tails elicited after 2-s depolar
a myocyte that was dialyzed with 100-μMH89 pipette solution for 26min and then expos
myocytes with those obtained frommyocytes that were pretreated with external H89, H89I, phorbol-12-myristate-13-acetate (PMA), forskolin, LY294002, 1-(5-isoquinoli-
nesulfonyl)-2-methylpiperazine (H7), N-[2-(methylamino)ethyl]-5-isoquinolinesul-
fonamide (H8), N-[2-((p-romocinnamyl)amino)ethyl]-5-isoquinolinesulfonamide
(H89), PD98059, tyrphostin A1, and tyrphostin A25 were obtained from
Calbiochem, prepared as stock solutions in DMSO (Sigma-Aldrich), stored in the
dark at −20 °C, and added to experimental solutions as required. The maximum
concentration of DMSO in bathing solutionswas 0.1%, a concentration that has little
effect on IKs [15]. Solutions were protected from light during experiments.
2.5. Statistics
Experimental data are expressed as means±SEM, and Student's t-test or one-
way ANOVA followed by Dunetts Multiple Comparison test was used to deter-
mine the significance of drug effects. Differences were considered significant when
P < 0.05.
3. Results
The families of current records shown in Fig. 1Awere obtained
from a myocyte that was held at −70 mV, briefly depolarized to
prepulse potential −30 mV , and then depolarized for 2 s to po-
tentials between −10 and +90 mV. The 2-s depolarizations ac-
tivated time-dependent outward IKs, and the repolarizations to
−30 mV elicited deactivating IKs tails. Changing the superfusate) Data obtained from amyocyte that was pretreated with 10 μMH89 for 18 min, and
izations; right: tail current–voltage relationships. (B) Time plot of IKs tail amplitude in
ed to hyposmotic solution. (C) Comparison of the results obtained from control (Ctl)
pipette (pip) solution, and H8 pipette solution. Number of myocytes in parentheses.
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increases in the amplitudes of the two IKs components (Fig. 1A).
A plot of tail current amplitude versus depolarization voltage
illustrates that the hyposmotic stimulation of IKs did not involve
a shift in the voltage dependence of IKs activation (Fig. 1A). In
agreement with earlier studies [6,16], neither the voltage for
half-maximal activation of IKs, the slope of the activation rela-
tionship, nor the time course of IKs activation at +50 mV were
significantly altered by hyposmotic superfusion (n=8; data not
shown).
In many of the figures that follow, we show representative
records obtained using 2-s depolarizations. These were
collected at suitable break periods in the regular 0.1-Hz pulsing
(prepulse −30 mV to +50 mV for 500 ms) used to monitor and
quantify the effects of interventions on the amplitude of the IKs
tail. The time plot of IKs tail amplitude shown in Fig. 1B
illustrates that hyposmotic stimulation of the current began after
a short lag and reached a steady state within 5 min. When
chromanol 293B (50 μM), an established cardiac IKs blocker
[17] with IC50 ≈8.8 μM [18], was added to the hyposmotic
solution, there was a rapid reduction in the amplitude of the
tail current (also see Fig. 1A). The degree of inhibition of
current by the drug was the same in myocytes superfused with
hyposmotic solution as in those superfused with isosmotic
solution (Fig. 1C).Fig. 3. Hyposmotic stimulation of IKs in myocytes pretreated with PKC inhibi
solutions for 20–25 min. This pretreatment blocked stimulation of IKs by 0.1
(C) Tail currents recorded from a myocyte that was pretreated with 1 μM bisin
solution for 5 min (right). Calibration bar indicates 0.5 nA. (D) Summary of th
parentheses.3.1. Hyposmotic stimulation of IKs following inhibition of PKA,
PKG, and PKC activity
H89 [19,20] and H8 [21] were used to inhibit the activities of
PKA and PKG, and H7 [21] and bisindolylmaleimide I (Bis)
[22] were used to inhibit the activity of PKC.
3.1.1. Experiments with H89 and H8
H89 inhibits PKA and PKG by interfering at the level of the
ATP binding site of the catalytic domain of these kinases (IC50
(PKA)≈50 nM; IC50 (PKG)≈500 nM [20,21]). The compound
has previously been used at external concentrations between 1
and 10 μM [23–28] to investigate the regulation of cardiac ion
channels by PKA. In particular, 10-min pretreatments with
either 10 μM H89 attenuated forskolin-induced stimulation of
cardiac Ca2+ and Cl− currents by 70–80% [23–28], and
attenuated isoprenaline-induced stimulation of cardiac IKs by
nearly 100% [27]. The data in Fig. 2A and D indicate that
pretreatment of myocytes with 10 μMH89 for 14±2 min (n=6)
or 20 μM H89 for 17±3 min (n=8) had little effect on the
response of IKs to hyposmotic solution. In another series of
experiments, myocytes were pretreated with H89 by dialyzing
them for 20±2 min with 100-μM H89 pipette solution.
Subsequent superfusion with hyposmotic solution increased
the amplitude of IKs by 80±17% (n=4), a value similar to thetors. (A, B) Test myocytes were dialyzed and superfused with 50-μM H7
μM PMA (A), but did not block stimulation by hyposmotic solution (B).
dolylmaleimide I (Bis) for 15 min (left), and then exposed to hyposmotic
e data. Same control (Ctl) myocytes as in Fig. 2. Number of myocytes in
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control myocytes (Fig. 2B, D).
H8 inhibits PKA and PKG with IC50 values near 1.2 and
0.5 μM, respectively [21]. In the present study, we dialyzed
myocytes with 200-μM H8 pipette solution for 30 min to inhibit
the activities of these kinases. The protocol was judged to be
effective because the response of IKs amplitude to test application
of 1 μM isoprenaline was severely blunted (increase of 15±3%
(n=8), versus increase of 143±9% (n=6) in control myocytes).
For the hyposmotic trials, myocytes were dialyzed with H8
solution for 30 min, and then exposed to hyposmotic solution. In
ten myocytes, the hyposmotic solution increased the amplitude of
IKs by a control-like 83±14% (Fig. 2C).
3.1.2. Experiments with H7 and bisindolylmaleimide I
To suppress PKC activity, myocytes were pretreated with H7
by including the inhibitor (50 μM) in both the pipette solution and
the superfusate. In matched experiments on control and H7-
dialyzed myocytes, application of PKC activator PMA (0.1 μM)Fig. 4. Hyposmotic stimulation of IKs in myocytes pretreated with kinase stimulant
forskolin for ≈5 min, and then exposed to hyposmotic forskolin solution. Forskolin st
but did not occlude further stimulation by hyposmotic solution. Note that the forsk
current) was unaffected by hyposmotic solution. (B) Current records obtained from a
hyposmotic ATP solution. (C) Summary of the effects of hyposmotic solution on
acetylcholine (ACh), PMA, angiotensin II (Ang II), and ATP. Pretreatments did not oc
myocytes as in Fig. 2. Number of myocytes in parentheses.at 20 min post-patch increased the amplitude of IKs by 51±7%
(n=7) in control myocytes, and by just 8±6% (n=5) in H7-
pretreated myocytes (P<0.001) (Fig. 3A). Nevertheless, hypos-
motic solution increased the amplitude of IKs by 88±10% (n=8)
in myocytes pretreated with H7 for 20–25 min.
Bisindolylmaleimide I is a potent inhibitor of PKC (IC50≈
70 nM [19,22]) that has been used at external concentrations up to
0.2 μM to investigate the regulation of cardiac ion channels by
PKC [25,28–30]. In the present study, pretreatment of myocytes
with a 1-μM concentration of the inhibitor for≈15 min had little
effect on the response of IKs to hyposmotic solution (increase of
68±9%; n=6) (Fig. 3C, D).
3.2. Hyposmotic stimulation of IKs during stimulation of kinase
activity
3.2.1. Experiments with forskolin
To determine whether strong stimulation of IKs via ac-
tivation of the cAMP-PKA pathway occluded additionals. (A) Current records obtained from a myocyte that was pretreated with 5 μM
imulated time-dependent IKs during depolarization and tail IKs on repolarization,
olin-induced increase in early time-independent current (most likely CFTR Cl−
myocyte that was pretreated with 20 μM ATP for ≈5 min and then exposed to
the amplitude of the IKs tail in myocytes that were pretreated with forskolin,
clude strong stimulation of IKs by hyposmotic 0.75T solution. Same control (Ctl)
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were pretreated with micromolar forskolin for 5–8 min, and
then exposed to hyposmotic forskolin solution. Although the
application of forskolin resulted in a strong increase in the
amplitude of IKs, it did not occlude a further increase in
amplitude when the myocyte was exposed to hyposmotic
solution (Fig. 4A). In fact, the increases observed in myocytes
that were pretreated with 1 and 5 μM forskolin (77±5% (n=6)
and 65±7% (n=10), respectively) were not significantly dif-
ferent than the 74±6% (n=41) increase observed in control
myocytes (Fig. 4C).
3.2.2. Experiments with PMA
Three myocytes were pretreated with 0.1 μMPMA for 10 min
to pre-activate PKC, and then challenged with hyposmotic PMA
solution. The hyposmotic solution increased the amplitude of IKs
by a control-like 82±16% (Fig. 4C).
3.2.3. Experiments with receptor agonists
Myocytes were pretreated for 5 min with one of the following
agonists: 10 μM acetylcholine to activate muscarinic receptorsFig. 5. Hyposmotic stimulation of IKs in myocytes that were pretreated with GDPβS,
in representative myocytes that were pretreated with 10-mM GDPβS pipette solutio
with storage solution that contained 50 μM PD98059 (B). (C) Summary of the effects
with 10 mMGDPβS dialysate for 12–17 min, 10 μM cytochalasin D (CytD) for 13–1
above. Same control (Ctl) myocytes as in Fig. 2. Number of myocytes in parenthesand stimulate PKG activity [31], 20 μM ATP to activate Gαq-
coupled purinergic receptors and stimulate PKC activity [32,33],
and 0.1 μM angiotensin II to activate Gαq-coupled AT1 receptors
and stimulate PKC activity [34,35]. However, none of these
pretreatments affected the stimulation of IKs by hyposmotic
solution (Fig. 4B, C).
3.3. Possible involvement of G-proteins, cytoskeleton, PI3-K,
and MAPKs in the hyposmotic stimulation of IKs
Hyposmotic swelling can cause activation of GTP-binding
proteins [36,37] that have been implicated in a number of swell-
ing-induced phenomena, including reorganization of the actin
cytoskeleton, increased phosphorylation of p125 focal adhesion
kinase, activation of PI3-K, and activation of volume-sensitive
Cl− channels [38,39]. Other mechanisms may also be involved in
swelling-induced activation of PI3-K [12,40] and consequent
activation of MAPKs [13,41–43]. In the present study, we used
selective inhibitors to evaluate the involvement of G-proteins,
cytoskeleton, PI3-K, and MAPKs in the hyposmotic stimulation
of IKs.cytochalasin D, LY294002, and PD98059. (A, B) Hyposmotic stimulation of IKs
n (A), and 50 μM PD98059 pipette solution following 2 h pre-patch incubation
of hyposmotic solution on the amplitude of IKs in myocytes that were pretreated
5 min, 10 μMLY294002 (LY) for ≈15 min, and 50 μM PD98059 (PD) as noted
es.
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Myocytes were dialyzed for ≈15 min with a pipette solution
that contained inhibitory GDPβs (10 mM) [44,45], and then
exposed to hyposmotic solution. The pretreatment had little effect
on the amplitude of the IKs tail, and no effect on stimulation of the
current by hyposmotic solution (n=4) (Fig. 5A, C). Similarly,
pretreatment with 10 μM cytochalasin D for 10–15 min (which
has been reported to disrupt the cytoskeleton in guinea-pig
ventricular myocytes [46]) had no apparent effect on either basal
IKs or the stimulation of IKs by hyposmotic solution (increase
of 77±10%; n=4) (Fig. 5C).
3.3.2. MAPKs
To evaluate the role of MAP kinase (ERK1 and 2 subfamilies)
in the hyposmotic stimulation of IKs, myocytes were pretreated
with MAP kinase kinase (MEK) inhibitor PD98059 [47] for
2-h pre-patch, dialyzedwith pipette solution that contained 50μM
PD98059, and then exposed to hyposmotic solution. In these
myocytes, hyposmotic solution increased the amplitude of IKs by
a control-like 71±7% (n=6) (Fig. 5B, C).
3.3.3. PI3-K
Myocytes were pretreated with PI3-K inhibitor LY294002
(10 μM) [19] for ≈15 min, and then exposed to hyposmoticFig. 6. Hyposmotic stimulation of IKs in myocytes pretreated with tyrphostins and Ks
inhibitor tyrphostin A25 (A25) for 6.5 min. Note the relatively weak stimulation of
Comparison of the data obtained from control (Ctl) myocytes (see Fig. 2) with those
tyrphostin A1 (A1). *P<0.01 versus control and tyrphostin A1. (C) Control-like stim
and 50 μM chromanol 293B (293B). Number of myocytes in parentheses.solution. The inhibitor had no effect on the response of IKs to
hyposmotic solution (increase of 70±14%; n=3) (Fig. 5C).
3.4. Possible involvement of TK in the hyposmotic stimulation
of Ks channel activity
It has been suggested that tyrosine phosphorylation plays an
important role in the acute responses of several ionic con-
ductances to osmotic stress [37,48,49]. To obtain direction on
whether tyrosine phosphorylation is involved in the stimulation
of IKs by hyposmotic solution, we investigated the effects of TK
inhibitor tyrphostin A25 and TK-inactive tyrphostin A1 [50].
Myocytes were pretreated with 20 μM tyrphostin A25 for 6–
8 min, and then exposed to hyposmotic solution. The
pretreatment decreased the amplitude of basal IKs, and attenuated
the stimulatory effect of hyposmotic solution on the current. In
the example shown in Fig. 6A, the pretreatment reduced IKs by
65%, and the exposure to hyposmotic solution increased the
current by just 16%. The blunted response was not due to a
deterioration of the myocyte or to a rundown of IKs because
subsequent application of drug-free isosmotic solution restored
the amplitude of the current to within 10% of its pre-drug value
(Fig. 6A). In six experiments with the TK inhibitor, exposure
to hyposmotic solution only increased the amplitude of IKs bychannel blockers. (A) Data obtained from a myocyte that was pretreated with TK
current during subsequent superfusion with hyposmotic tyrphostin solution. (B)
obtained from myocytes pretreated with tyrphostin A25 and inactive analogue
ulation of IKs in myocytes pretreated for 5 min with 30 μM thiopentone (THIO)
Fig. 7. Effects of hyposmotic solution and tyrphostin A25 on KCNQ1/KCNE1 current in transfected BHK cells. (A) Effect of hyposmotic 0.75T solution on the
amplitude of KCNQ1/KCNE1 tail current (Itail) in a representative cell. (B) Membrane currents recorded before (0.75T) and 5 min after switching from hyposmotic
to isosmotic (1T) solution. (C) Records of tail currents obtained from a transfected cell that was pretreated with 10 μM tyrphostin A25 (A25) for 8 min (left) and then
exposed to hyposmotic solution for 5 min (right). (D) Comparison of the percentage increases in tail current amplitude induced by hyposmotic solution in control
(Ctl) and tyrphostin A25-pretreated cells. The tail currents were recorded at −40 mVafter 0.5 s pulses to +50 mV. *P<0.01 versus control cells. Number of cells in
parentheses.
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had little effect on either basal IKs or the stimulation of current
by hyposmotic solution (increase of 69 ± 4%; n=4) (Fig. 6B).
It seemed unlikely that the selective suppression of basal IKs by
tyrphostin A25 was by itself responsible for the subsequent
depression of hyposmotic stimulation of the current. Never-
theless, we mimicked tyrphostin attenuation of basal IKs by
using two Ks channel blockers, thiopentone (30 μM) [51] and
chromanol 293B (50 μM). These compounds reduced the
amplitude of basal IKs by 49±6% (n=4) and 76±5% (n=3),
respectively, but failed to affect subsequent stimulation of the
current by hyposmotic solution (increases of 87±7% and 75±8,
respectively) (Fig. 6C).
To determine whether current in cells expressing Ks
channel subunits responded to hyposmotic swelling and
tyrphostin A25 in the same manner as IKs in myocytes,
experiments were conducted on BHK cells that were co-
transfected with KCNQ1 and KCNE1. Exposure of transfected
cells to hyposmotic 0.75T solution caused marked reversible
increases in the amplitude of time-dependent current on
depolarization (+50 mV) and tail current on repolarization
(−40 mV) (Fig. 7A, B). On average, exposure to hyposmotic
solution for 5 min increased the amplitude of the tail current by
204±23% (n=6) (P<0.001). For the trials with tyrphostin A25,
cells were pretreated with a 10-μM concentration of the inhibitor
for 6–8 min. The pretreatment reduced the amplitude of the tail
current by 56±17% (n=4), and subsequent hyposmotic swelling
increased the amplitude by 92±22% (Fig. 7C, D). The latter value
is significantly (P<0.01) smaller than the 204±23% increase
registered in non-pretreated cells.4. Discussion
Mammalian cells respond to conditions that cause cell swelling
by strongly increasing the export of osmolytes via activation ofK+
and anion channels [12,13]. In the heart, these conditions include
hyponatremia andmyocardial ischemia–reperfusion [52–54], and
the response includes activation of delayed-rectifier Ks channels
[6–8,55]. The swelling-induced activation promotes repolariza-
tion and shortening of the action potential [6–8] which, in turn,
may restrict Ca2+ influx and protect myocytes against deleterious
Ca2+ overload [1]; on the other hand, the concomitant shortening
of the refractory period may predispose toward reentrant
arrhythmia [56].
In the present study, we used hyposmotic 0.75T solution to
swell guinea-pig ventricular myocytes, and found that the
intervention caused a 74±6% (n=41) increase in the am-
plitude of IKs. The magnitude of the increase is in line with the
78% increase (0.7T) measured by Sasaki et al. [7] in these
myocytes, and somewhat larger than the 46% (0.67T) and 39%
(0.7T) increases measured by Rees et al. [57] and Wang et al.
[58]. The hyposmotic stimulation reached a steady state in 3 to
5 min, and decayed just as quickly on re-admission of isos-
motic solution (e.g., Fig. 2B). These time courses are con-
sistent with the halftimes for stimulation (49±6 s) and decay
(41±3 s) reported in an earlier study on IKs in guinea-pig
ventricular myocytes exposed to hyposmotic 0.7T solution
[58]. A further point of agreement with earlier studies on these
myocytes [8,16,58] is that the dependence of IKs activation
on voltage was little affected by hyposmotic solution (e.g.,
Fig. 1A).
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cardiac IKs are unclear. However, one that incorporates an
enhanced phosphorylation of PKA-sites on Ks channel protein is
a plausible candidate because PKA-mediated phosphorylation
leads to large increases in IKs [59–61]. Earlier studies have con-
cluded that PKA is not involved in the hyposmotic response of IKs
because 10-min pretreatments with dialysates that contained
10 μM H89 and 100 μM H8, respectively, had little effect on the
response in guinea-pig [8] and canine [9] ventricular myocytes.
We have re-investigated the possible involvement of PKA by (i)
pretreating myocytes for longer times with higher concentrations
of PKA inhibitors than in earlier studies, and (ii) pretreating
myocytes with forskolin to pre-activate PKA. Since neither of
these interventions affected the hyposmotic stimulation of IKs, it
seems highly unlikely that the phenomenon is mediated via an
increase in PKA activity (or via a decrease in phosphatase activity
pertinent to channel PKA-sites).
PKG has recently been shown to have a positive regulatory
action on Ks channels in guinea-pig sinoatrial nodal cells [31].
However, it is unlikely that activation of PKG is involved in the
hyposmotic stimulation of IKs observed here because the kinase
was almost certainly inhibited in myocytes that were pretreated
with 100-μMH89 and 200-μMH8dialysates, i.e., the IC50 (PKG)
values for these compounds is near 0.5 μM [19–21].
PKC is another serine/threonine kinase known to be a positive
regulator of Ks channels in cardiac cells [59,62]. Groh et al. [8]
discounted a role for PKC in the hyposmotic stimulation of IKs
because a 10-min pretreatment with 10 μM chelerythrine failed to
suppress the stimulation. However, the present re-investigation of
the role of PKC was warranted because a recent study has con-
cluded that in marked contrast to bisindolylmaleimide I, chelery-
thrine is not an effective inhibitor of PKC [19]. Our approaches
were to inhibit PKC by pretreating myocytes with relatively high
concentrations of bisindolylmaleimide and H7, and to stimulate
PKC by pretreating them with phorbol ester PMA. The outcome
was that neither the inhibitory nor stimulatory pretreatments
affected the response of IKs to hyposmotic solution, rendering it
unlikely that PKC is involved in the hyposmotic stimulation.
Since it is known that hyposmotic stress activates protein
kinases ERK1/2 in both cardiac [63] and non-cardiac [13,48]
cells, and that inhibition of ERK1/2 activation by PD98059
abolishes swelling-induced activation of Cl− channels in rat
astrocytes [43], it seemed possible that activation of these kinases
might have a role in the hyposmotic activation of cardiac IKs. We
now view that as highly unlikely because hyposmotic stimulation
of IKs was unaffected in myocytes pretreated with 50 μM
PD98059. Although the present study provides no information on
the possible involvement of two other major subtypes of MAP
kinase, p38 and JNK, it is noteworthy that Sadoshima et al. [63]
found little change in the activities of these kinases during 10-min
swellings of rat ventricular myocytes.
Hyposmotic swelling activates PI3-K in both cardiac [63] and
non-cardiac cells (e.g., [13,40]). Swelling-induced activation of
PI3-K could modulate ion channel activity by promoting the
generation of lipid messengers and/or by stimulating the activity
of protein kinase B (PKB) [64,65]. However, it seems unlikely
that these mechanisms have a role in the hyposmotic stimulationof IKs because neither pretreatment of myocytes with PI3-K
inhibitor LY294002 (10 μM) nor PKB inhibitor H89
(IC50≈2.6 μM [19]) affected the hyposmotic response of IKs.
G-protein activity can be directly affected by mechanical
forces [66], and there is convincing evidence that small mono-
meric G-proteins and their downstream effectors are participants
in the hyposmotic activation of Cl− channels in a number of cell
types. Tilly et al. [38] found that Rho inhibitor Clostridium
botulinum C3 exoenzyme reduced osmosensitive anion efflux in
Intestine 407 cells, and Nilius et al. [37] observed that both the
toxin and Rho kinase blocker Y-27632 impaired GTPγS-
mediated activation of volume-sensitive Cl− channels in bovine
endothelial cells. Furthermore, expression of constitutively-active
Rho increased swelling-activated taurine (and K+) efflux in
NIH3T3 mouse fibroblasts [67]. In a study on N1E115 neuro-
blastoma cells, Estevez et al. [36] concluded that swelling-
activated Cl− channels in these cells are positively regulated by
Rho GTPase and negatively regulated by heterotrimeric Gαs via
phosphorylation-independent mechanisms. These investigators
also found that dialysis of cells with 10 mM GDPβS prevented
stimulation of the channels by GTPγS, suggesting that GDPβS
blocked Rho signaling pathways involved in the swelling
response. More directly, Voets et al. [68] found that dialysis
of bovine endothelial cells with 1 mM GDPβS pipette solution
strongly attenuated hyposmotic activation of Cl− channels. In
marked contrast, we found that hyposmotic stimulation of IKs was
unaffected by 10 mM GDPβS pipette solution, suggesting a lack
of involvement of Rho, its effectors, and heterotrimericG proteins
in the stimulation.
Actin-disrupter cytochalasin D [69] has frequently been
employed to assess the involvement of the cytoskeleton in osmo-
sensitive signaling. Pretreatment of cells with micromolar
cytochalasin D inhibited the effects of hyposmotic solution on
volume-sensitive Cl− current in rat epithelial cells [70], Na+
channels in epithelial A6 cells [71], L-type Ca2+ channels in
guinea-pig gastric myocytes [72], and T-type Ca2+ channels in
guinea-pig ventricular myocytes [46]. Pretreatment with 1 μM
cytochalasin D also attenuated/abolished the hyposmotic stimu-
lation of currents carried by Ca2+-activated K+ channels [73] and
KCNQ1 channels [74] expressed in Xenopus oocytes. In the
present study, pretreatment of myocytes with 10 μM cytochalasin
D had no effect on the response of IKs to hyposmotic solution.
Interestingly, a similar pretreatment had little effect on pressure-
inflation-induced stimulation of IKs in an earlier study on guinea-
pig ventricular myocytes [58]. Since cytochalasin D can disrupt
integrin signaling in cardiac myocytes [75], these results may
indicate a lack of involvement of stress-sensitive integrin in the
hyposmotic stimulation of IKs.
There is accumulating evidence that TK is an important
modulator of ion channels [76] and their responses to hyposmotic
cell swelling [77]. In regard to a possible role for TK in the
hyposmotic response of cardiac Ks channels, it has been reported
that pretreatment of canine ventricular myocytes with TK
inhibitor genistein (50 μM) partially attenuated the stimulation
of IKs by hyposmotic solution [9]. On the other hand, pretreatment
of COS-7 cells with 50 μM genistein had no effect on the
stimulation of KCNQ1 and KCNQ1/KCNE1 channel currents by
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effects of TK inhibitor tyrphostin A25 and inactive analogue
tyrphostin A1 on both IKs in myocytes and KCNQ1/KCNE1
current in BHK cells. Basal IKs and basal KCNQ1/KCNE1
current were inhibited by tyrphostin A25, but not by tyrphostin
A1, suggesting that the effect of tyrphostin A25 was due to an
inhibition of TK rather than to a direct block of the channels. In
myocytes and cells that were pretreated with tyrphostin A25, the
stimulatory responses of IKs and KCNQ1/KCNE1 current to
hyposmotic solution were far weaker than in non-pretreated
preparations. This action of tyrphostin A25 was not replicated by
tyrphostin A1, suggesting that it was mediated by an inhibition of
TK and consequent lowering of phosphorylation on tyrosine
residues of channel protein (or channel-regulatory protein). A
search for putative tyrosine phosphorylation sites on KCNQ1 and
KCNE1 proteins using NetPhos software [78] reveals that there
are at least seven high-score sites on KCNQ1 (Y51, Y111, Y171,
Y184, Y395, Y461, Y662), and one on KCNE1 (Y94). Future
studies incorporating site-directed mutagenesis of these putative
phosphorylation sites are expected to shed further light on the role
of TK in the hyposmotic stimulation of cardiac Ks channels.
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